Becker's Healthcare January 22, 2025
Claire Wallace

Guardant Health has secured Medicare coverage from Palmetto for its blood test to monitor for disease recurrence in patients with colorectal cancer.

Guardant, a biotechnology company, provides a blood test on Guardant’s Smart Liquid Biopsy platform that uses epigenomic analysis to detect circulating tumor DNA to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Insurance, Medicare, Pharma / Biotech
Closing the women’s health gap: Biopharma’s untapped opportunity
The next 15 drugs for Medicare price negotiations
Medicare Negotiations Could Fuel, Not Stifle, Innovation
Four Opportunities To Revitalize The US Biomedical Research Enterprise
FDA approves 1st monotherapy drug for treatment-resistant depression

Share This Article